RMMS Recognized as Industry Leaders by LMG Life Sciences -
RMMS Secures Reversal Before Federal Circuit, Invalidating Asserted Patents Concerning Latisse® (bimatoprost) Ophthalmic Solution -
U.S. Court Of Appeals For The Federal Circuit Affirms RMMS's Victory Involving Generic Ibandronate Products -